Top Markets
#1 CoW Protocol CoW Protocol +59.73%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +39.17%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.40%
#6 Humanity Humanity +22.30%
#7 Enso Enso +17.07%
#8 Velvet Velvet +17.00%
#9 Tutorial Tutorial +16.94%
#10 Huma Finance Huma Finance +14.02%
Coin of the day
CoW Protocol CoW Protocol
設定
言語
日本
通貨
USD
テーマ
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
株式のランク #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
株価
$0.6
最終同期: 2024-08-14
時価総額
$2.09M
変化（1日）
0.00%
変化（1年）
0.00%
国
SG
取引 ASLAN Pharmaceuticals Limited (ASLN)

カテゴリー

Healthcare
ASLAN Pharmaceuticals Limited（ASLN）のP/B比率
August 2026 時点のP/B比率 TTM: -0.19
ASLAN Pharmaceuticals Limited の最新の財務報告および株価によると、現在のP/B比率（TTM）は -0.19 です。2022 年末時点でのP/B比率は 0.96 でした。
ASLAN Pharmaceuticals Limited の P/B 比率の履歴（2014 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) -0.19 -11.57%
2023 -0.21 -121.55%
2022 0.96 135.76%
2021 0.41 -118.92%
2020 -2.15 -82.88%
2019 -12.58 -1,216.28%
2018 1.13 -10.51%
2017 1.26 11.69%
2016 1.13 -308.68%
2015 -0.54 496.91%
2014 -0.09 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -3,515.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -3,460.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -1,963.87%
BE